Vivalto Partners announces new investment in Linnea SA

Vivalto Partners announces the 100% acquisition of Linnea -a leading international pharmaceutical manufacturer of botanical ingredients-, formerly a joint-venture between Ipsen and Schwabe, through a primary buyout supported by management.